Your browser doesn't support javascript.
loading
Antibody responses to BNT162b2 mRNA COVID-19 vaccine in 2,015 healthcare workers in a single tertiary referral hospital in Japan
Takahiro Kageyama; Kei Ikeda; Shigeru Tanaka; Toshibumi Taniguchi; Hidetoshi Igari; Yoshihiro Onouchi; Atsushi Kaneda; Kazuyuki Matsushita; Hideki Hanaoka; Taka-Aki Nakada; Seiji Ohtori; Ichiro Yoshino; Hisahiro Matsubara; Toshinori Nakayama; Koutaro Yokote; Hiroshi Nakajima.
Afiliação
  • Takahiro Kageyama; Chiba University
  • Kei Ikeda; Chiba University
  • Shigeru Tanaka; Chiba University
  • Toshibumi Taniguchi; Chiba University
  • Hidetoshi Igari; Chiba University
  • Yoshihiro Onouchi; Chiba University
  • Atsushi Kaneda; Chiba University
  • Kazuyuki Matsushita; Chiba University
  • Hideki Hanaoka; Chiba University
  • Taka-Aki Nakada; Chiba University
  • Seiji Ohtori; Chiba University
  • Ichiro Yoshino; Chiba University
  • Hisahiro Matsubara; Chiba University
  • Toshinori Nakayama; Chiba University
  • Koutaro Yokote; Chiba University
  • Hiroshi Nakajima; Chiba University
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21258188
ABSTRACT
We measured antibody responses in 2,015 healthcare workers who were receiving 2 doses of BNT162b2 mRNA vaccine against SARS-CoV-2. The vast majority (99.9%) had either seroconversion or a substantial increase in antibody titer. A multivariate linear regression model identified predictive factors for antibody responses which may have clinical implications.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...